10/21/2020 5:16:43 PM
ImmunityBio And NantKwest Announce First Patient Dosed In Phase 1 Clinical Trial Of HAd5-COVID-19
10/15/2020 6:03:25 AM
ImmunityBio: FDA Authorizes To Begin Phase I Clinical Trial Of HAd5-COVID-19
9/10/2020 9:14:33 AM
Brink Biologics Announces License Agreement With Fresenius Kabi SwissBioSim GmbH
8/24/2020 9:04:51 AM
NantKwest, ImmunityBio Sign Deal For Joint Development, Commercialization Of COVID-19 Vaccine And Related Therapeutics
8/10/2020 7:28:18 AM
CBR By Generate Life Sciences And NantKwest To Develop COVID-19 Treatment Leveraging Newborn Stem Cells
6/25/2020 1:04:34 AM
NantKwest Announces Pricing Of Public Offering Of 7.41 Mln Shares
6/24/2020 4:17:06 PM
NantKwest Announces Proposed Public Offering Of Common Stock